NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 194 filers reported holding NOVAVAX INC in Q2 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $95,000 | -69.2% | 50,800 | -77.9% | 0.00% | -50.0% |
| Q2 2018 | $308,000 | -64.7% | 230,300 | -44.6% | 0.01% | -60.0% |
| Q1 2018 | $872,000 | +1837.8% | 415,500 | +1057.4% | 0.02% | +1400.0% |
| Q1 2017 | $45,000 | -99.1% | 35,900 | -99.1% | 0.00% | -99.2% |
| Q4 2016 | $4,767,000 | +310.9% | 3,784,100 | +578.5% | 0.12% | +215.8% |
| Q3 2016 | $1,160,000 | -42.7% | 557,700 | +100.4% | 0.04% | -59.6% |
| Q2 2016 | $2,023,000 | +95.3% | 278,300 | +89.8% | 0.09% | +20.5% |
| Q3 2015 | $1,036,000 | -17.3% | 146,600 | +30.4% | 0.08% | -58.7% |
| Q2 2015 | $1,252,000 | +33.0% | 112,400 | -1.2% | 0.19% | +110.0% |
| Q1 2015 | $941,000 | +779.4% | 113,800 | +525.3% | 0.09% | +429.4% |
| Q4 2014 | $107,000 | -76.2% | 18,200 | -81.7% | 0.02% | -19.0% |
| Q1 2014 | $450,000 | – | 99,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |